This Week in Psychedelics - 9.25.20

ThisWeekinPsychedelics.png

Cannabis

  • Vermont Bills To Legalize Marijuana Sales And Expunge Convictions Head To Governor’s Desk (Marijuana Moment)

  • Barbados Is Inches Away From Decriminalizing Cannabis Possession (MERRY JANE)

  • Delta-8-THC Promises to Get You High Without the Paranoia or Anxiety (Discover Magazine)

  • New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce (Marijuana Moment)

  • ‘Failure’ to embrace medical cannabis has caused “preventable deaths” – report (Cannabis Health News)

  • Using weed during pregnancy linked to psychotic-like behaviors in children, study finds (CNN)

  • Texas Ban On Smokable Hemp Lifted Until 2021, Judge Rules (Marijuana Moment)

  • Playboy Gets Serious About Cannabis Law Reform Advocacy With New Partnership, Grants (Forbes)

  • Study: Use of Cannabis Long-Term Not Associated with Cognitive Differences in Older Adults (NORML)

  • FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences (Marijuana Moment)

  • Survey: Nearly One in Three Migraine Sufferers Have Used Cannabis for Symptom Management, Most Report It to Be Effective (NORML)

  • South Dakota Voters Support Medical And Recreational Marijuana Initiatives, New Opposition Poll Finds (Marijuana Moment)

Magic Mushrooms

  • Oregon Democratic Party Endorses Legal Psilocybin Therapy And Drug Decriminalization Ballot Measures (Marijuana Moment)

  • MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin (PR Newswire)

  • Inside 9/20, the Holiday for Psychedelic Mushrooms (Rolling Stone)

MDMA

  • Ecstasy use down during pandemic; Psychedelics draw more interest (NL Times)

Ayahuasca

  • Tribute to Dr. Domingos Bernardo, the Legal Expert who Fought for the Liberation of Ayahuasca in Brazil (1941-2020) (Chacruna)

Novel Psychoactive Substances

  • Mindset Pharma Reports Positive Results of Synthetic Psilocybin-Inspired Compounds (Lucid News)

Ketamine

  • This Wearable Ketamine Device Could Be The Future Of Pain Management (Forbes)

Miscellaneous

  • Ann Arbor Decriminalizes Psychedelics (DoubleBlind)

  • COMPASS Pathways Closes $147 million IPO (Psilocybin Alpha)

  • President Behind Mexico’s War on Drugs Admitted It Was ‘Unwinnable’ (VICE)

  • The Legal Response to Breonna Taylor's Death Shows How Drug Prohibition Transforms Murder Into Self-Defense (Reason)

  • Who Will Benefit From Psychedelic Medicine? (The Washington Post)

  • Mind Cure Becomes Latest Publicly-Traded Psychedelic Company (Psilocybin Alpha)

  • 60 Percent of DC Voters Support Plant Medicine Decriminalization (Lucid News)

  • MindMed Applies to List on Nasdaq (Psilocybin Alpha)

  • Can Psychedelics Rekindle Ancient Animism in Modern Society? (DoubleBlind)

  • Meet the ‘psychedelic concierge’ to the stars (Page Six)

  • Why Psychedelic Therapy is Effective at Combating Addiction (Sam Woolfe)

  • Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration (Psilocybin Alpha)

  • Dr. Michael Mithoefer & Ann Mithoefer from MAPS Join AWAKN's Scientific Board (Stockhouse)

  • The Psychedelic Election is an Internet Addiction (Lucid News)

  • An Interview with Mariavittoria Mangini (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.